ALGS

Aligos Therapeutics
ALGS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$47.15M
EV
$-82.84M
Shares Outstanding
6.11M
Beta
2.69

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$90.33
P/E 2025E
-
P/Revenue 2025E
25.21x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Aligos Therapeutics, Inc.

gainify
ALGS

Aligos Therapeutics, Inc.

ALGS

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a c...

Sector

Healthcare

Industry

Biotechnology

CEO

Blatt, Lawrence

Employees

70

IPO Date

2020-10-16

Headquarters

One Corporate Drive, 2nd Floor, South San Francisco, California, 94080, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.